These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 5978465)

  • 41. [Electroencephalographic study in patients with cerebral arteriosclerotic lesions. Modifications induced by hemokinetic treatment in course of a barbiturate narcosis].
    Ruggerini R; Grugni P; Bolognesi L; Romitti M; Poggi G; Senini G
    Minerva Anestesiol; 1971 Apr; 37(4):164-73. PubMed ID: 5566169
    [No Abstract]   [Full Text] [Related]  

  • 42. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients.
    Labios M; Martínez M; Vayá A; Gabriel F; Guiral V; Aznar J
    Clin Hemorheol Microcirc; 1999; 21(2):79-85. PubMed ID: 10599590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experience with the medical treatment of chronic cerebrovascular insufficiency: bamethan and inositol nicotinate versus placebo].
    Cucinotta D; Silvestrini C; Mancini M; Maini C; Passeri M
    G Clin Med; 1981 May; 62(5):339-50. PubMed ID: 6115790
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
    Schneider H
    Z Allgemeinmed; 1971 Dec; 47(36):1916-8. PubMed ID: 5003958
    [No Abstract]   [Full Text] [Related]  

  • 46. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 47. [Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
    Pometta D
    Ther Umsch; 1970 Mar; 27(3):128-32. PubMed ID: 5437609
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical evaluation of Provasan].
    Wodniecki J; Wolański A
    Wiad Lek; 1970 Oct; 23(20):1791-3. PubMed ID: 5482235
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapy of hyperlipemia using xantinol-nicotinate].
    Möller-Hardenack B
    Med Monatsschr; 1973 Aug; 27(8):370-2. PubMed ID: 4756297
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug therapy of cerebral arteriosclerosis in the senile age].
    Mankovsky N; Mints A
    G Gerontol; 1972 Jan; 20(1):42-9. PubMed ID: 5023587
    [No Abstract]   [Full Text] [Related]  

  • 51. [Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
    Sigroth K
    Lakartidningen; 1971 Apr; 68(15):1765-7. PubMed ID: 5577250
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A
    Atti Soc Ital Cardiol; 1969 Jan; 2():251-60. PubMed ID: 5406537
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
    Caruzzo C; Enrico-Bena L; Carnaghi R
    Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
    [No Abstract]   [Full Text] [Related]  

  • 54. [Familial hypercholesterolemic cutaneo-tendineous xanthomatosis].
    Degos R; Civatte J; Larrègue M; Dao C
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):781-4. PubMed ID: 5384202
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prophylactic and therapeutic perspectives in arteriosclerosis].
    Masini V; Concina B
    Policlinico Prat; 1967 Jul; 74(27):901-24. PubMed ID: 4885120
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experience in the treatment of arteriosclerotic circulatory disorders using Seniosan in the general practice].
    Rölke H
    Med Welt; 1969 Mar; 13():746-50. PubMed ID: 4185050
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment with nicotinic acid of patients with ischemic heart disease and hypercholesterolemia. II. Influence on the liver].
    Kubasta M; Nizník J; Jezdinská V; Vrána J; Vaverková H; Podivínský R; Zmeskal A
    Vnitr Lek; 1971 Feb; 17(2):154-62. PubMed ID: 5546846
    [No Abstract]   [Full Text] [Related]  

  • 58. [Arteriosclerosis and nicotinic acid therapy. 4. Nicotinic acid therapy].
    Ribom U
    Lakartidningen; 1971 Apr; 68(15):1750-2. PubMed ID: 5577246
    [No Abstract]   [Full Text] [Related]  

  • 59. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical results of the use of thrombosamine-heparin].
    Sudre Y; Bellet M; Bernadou M
    J Med Bord; 1965 May; 142(5):868-72. PubMed ID: 5830456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.